ESSA Pharma to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference

Rhea-AI Summary

ESSA Pharma Inc. (NASDAQ: EPIX) announced its participation in the 2022 Bloom Burton & Co. Healthcare Investor Conference on May 2, 2022, at 2:30 p.m. ET. The company's President and CEO, David R. Parkinson, will host one-on-one meetings along with COO Peter Virsik and CFO David S. Wood. The event will be held at the Metro Toronto Convention Centre, offering investors insights into the latest developments in the healthcare sector. A webcast of the presentation will be available on ESSA's website and archived for 90 days.

SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, April 26, 2022 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the 2022 Bloom Burton & Co. Healthcare Investor Conference on Monday, May 2, 2022 at 2:30 p.m. Eastern Time.

David. R. Parkinson, President and Chief Executive Officer of ESSA Pharma, will participate in and host one-on-one meetings. Peter Virsik, ESSA's Chief Operating Officer, and David S. Wood, ESSA's Chief Financial Officer, will also be participating in the one-on-one meetings.

Presentation Details

Presentation Date:	Monday, May 2, 2022
Presentation Time:	2:30 p.m. ET
Location:	Metro Toronto Convention Centre

About the Bloom Burton & Co. Healthcare Investor Conference

The Bloom Burton & Co. Healthcare Investor Conference brings together U.S., Canadian and international investors who are interested in the latest developments in the Canadian healthcare sector. Attendees will have an opportunity to obtain corporate updates from the premier Canadian publicly traded and private companies through presentations and private meetings.

About ESSA Pharma Inc.

ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma.

A webcast of the presentation can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the presentation, the webcast will be archived for 90 days.

View original content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-the-2022-bloom-burton--co-healthcare-investor-conference-301533609.html

SOURCE ESSA Pharma Inc

FAQ

When is ESSA Pharma presenting at the Bloom Burton & Co. Healthcare Investor Conference?

ESSA Pharma will present on May 2, 2022, at 2:30 p.m. Eastern Time.

Where is the Bloom Burton & Co. Healthcare Investor Conference taking place?

The conference is being held at the Metro Toronto Convention Centre.

Who from ESSA Pharma will be participating in the conference?

David R. Parkinson, Peter Virsik, and David S. Wood will participate in the conference.

How can I access the webcast for ESSA Pharma's presentation?

The webcast can be accessed on ESSA's website in the Investors/Events & Presentations section and will be archived for 90 days.

What is the focus of ESSA Pharma as a company?

ESSA Pharma focuses on developing novel therapies for the treatment of prostate cancer.